Načítá se...
Statin use in prediabetic patients: rationale and results to date
Prediabetes increases the risk for new-onset diabetes mellitus in patients receiving statins and this risk is dose- and time- dependent. Explanations for the conversion of a predisposed individual to diabetes are ambiguous including reductions in ubiquinone and adiponectin levels. However, the risk...
Uloženo v:
| Vydáno v: | Ther Adv Chronic Dis |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
SAGE Publications
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4549696/ https://ncbi.nlm.nih.gov/pubmed/26336593 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040622315596118 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|